Research Centre | Company Search | Charting | Stock Screener | Performance Tables | Financial Diary | Investing Board
AstraZeneca (AZN)
Share Price: 5,601.00p Change Today: -8.00p  Market Cap: 70,952m

AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

AstraZeneca Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 25,711.00 3,267.00 505.00¢ 9.3 n/a -26% 280.00¢ 6.0%
31-Dec-14 26,095.00 1,246.00 428.00¢ 14.0 n/a -15% 280.00¢ 4.7%
31-Dec-15 23,641.00 3,069.00 426.00¢ 14.2 n/a -0% 280.00¢ 4.6%
31-Dec-16 21,319.00 3,552.00 431.00¢ 13.5 13.5 +1% 280.00¢ 4.8%
31-Dec-17 20,152.00 2,227.00 428.00¢ 15.7 n/a -1% 280.00¢ 4.2%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AstraZeneca Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 17,168.43 3,948.12 253.78p 22.1 n/a -22% 215.16p 3.8%
31-Dec-19 18,379.81 4,331.35 290.58p 19.3 1.3 +14% 217.30p 3.8%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

AstraZeneca Company Announcements

FDA approves AZ's Lumoxiti in hairy cell leukaemia 14-Sep-2018 07:00 RNS
Tezepelumab FDA Breakthrough Therapy Designation 07-Sep-2018 07:00 RNS
Directorate Change 06-Sep-2018 07:00 RNS

Latest AstraZeneca Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Price Data

Currency UK Pounds
Share Price 5,601.00p
Change Today -8.00p
% Change -0.14 %
Volume 1,398,658
19-Sep-18 Close 5,601.00p
Shares Issued 1,266.78m
Market Cap 70,952m
Year End 31-Dec-17

What The Brokers Say

Strong Buy 17
Buy 1
Neutral 7
Sell 1
Strong Sell 4
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 09-Aug-18 15-Feb-18
Paid 10-Sep-18 19-Mar-18
Amount 90.00¢ 190.00¢

Trades for 19-Sep-2018

Time Volume / Share Price
17:02 151 @ 5,594.55p
16:53 600 @ 5,598.23p
16:53 300 @ 5,603.33p
16:52 2,644 @ 5,602.35p
16:52 2,500 @ 5,602.76p


www.bolsamania.com www.sharecast.com http://www.proshareclubs.co.uk/ www.digitallook.com